Palacio, Kyndel .
HRN: 05-96-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2023
CEFUROXIME 500MG (TAB)
05/14/2023
05/21/2023
ORAL
500mg
BID
Leukocytosis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes